|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||145.25 - 157.75|
|52 Week Range||19.31 - 189.26|
|Beta (5Y Monthly)||1.50|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||168.92|
Novavax CEO Stanley Erck joined Yahoo Finance Live to discuss the company's COVID-19 vaccine trial progress and his business outlook for the company.
Johnson & Johnson’s single-shot coronavirus vaccine wins FDA approval. Yahoo FInance’s Anjalee Khemlani breaks down the details.
The United States must stick to a two-dose strategy for the Pfizer-BioNTech and Moderna COVID-19 vaccines, top U.S. infectious disease official Anthony Fauci told the Washington Post newspaper. Fauci said that delaying a second dose to inoculate more Americans creates risks. He warned that shifting to a single-dose strategy for the vaccines could leave people less protected, enable variants to spread and possibly boost skepticism among Americans already hesitant to get the shots.